Alphatec Holdings, Inc. (NASDAQ: ATEC – News) recently announced the company has gone public. The company's initial public offering was 9,300,000 million shares of common stock at a price of $9 per share. Alphatec also granted the underwriters an option to purchase up to an additional 1,395,000 shares of common stock at the initial public offering price to cover over-allotments, if any.
Ronald G. Hiscock, CEO of Alphatec Spine, participated in the closing ceremony of the NASDAQ Stock Market Bell. Hiscock presided over the market close to celebrate Alphatec's initial public offering on the NASDAQ exchange.
In statements made at the ceremony, Hiscock spoke about the company's mission to provide unmatched service and taking scientific direction from the physician community.
"We have created a platform to build a major company and have put in place the infrastructure to support it," the CEO said. "Because of Alphatec's unique on-site manufacturing capability, we differentiate ourselves by being able to collaborate with surgeons to build customized products to meet their needs. We offer the fastest turn around on our customization than any other company in the industry."
In closing, Hiscock re-emphasized Alphatec's commitment to the surgeon, its customers, and its mission to provide quality care to patients.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc. is a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders.
Alphatec’s principal product offering is primarily focused on the U.S. spine fusion market through its wholly-owned subsidiary, Alphatec Spine, Inc., and includes a variety of spinal implant products and systems comprised of components such as spine screws, spinal spacers, and plates that offer multiple solutions to address patients' needs.
In addition to Alphatec's U.S. presence, the company also participates in the Japanese spine fusion and orthopedic trauma markets through its subsidiary, Alphatec Pacific, Inc.
Ronald G. Hiscock, CEO of Alphatec Spine, participated in the closing ceremony of the NASDAQ Stock Market Bell. Hiscock presided over the market close to celebrate Alphatec's initial public offering on the NASDAQ exchange.
In statements made at the ceremony, Hiscock spoke about the company's mission to provide unmatched service and taking scientific direction from the physician community.
"We have created a platform to build a major company and have put in place the infrastructure to support it," the CEO said. "Because of Alphatec's unique on-site manufacturing capability, we differentiate ourselves by being able to collaborate with surgeons to build customized products to meet their needs. We offer the fastest turn around on our customization than any other company in the industry."
In closing, Hiscock re-emphasized Alphatec's commitment to the surgeon, its customers, and its mission to provide quality care to patients.
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc. is a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders.
Alphatec’s principal product offering is primarily focused on the U.S. spine fusion market through its wholly-owned subsidiary, Alphatec Spine, Inc., and includes a variety of spinal implant products and systems comprised of components such as spine screws, spinal spacers, and plates that offer multiple solutions to address patients' needs.
In addition to Alphatec's U.S. presence, the company also participates in the Japanese spine fusion and orthopedic trauma markets through its subsidiary, Alphatec Pacific, Inc.